Active Balance and Cardio Care Intervention on Physical and Cardiovascular Health in People With Chronic Stroke

Launched by UNIVERSITY OF ILLINOIS AT CHICAGO · Sep 22, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new type of therapy called exergaming, which combines exercise with video games, to help improve physical function in people who have had a stroke. The goal is to see if this type of training is safe and effective compared to traditional rehabilitation methods. The researchers are particularly interested in how well participants can follow the program and if it actually helps them regain strength and mobility.

To be eligible for this study, participants should be between 45 and 90 years old, have experienced a stroke at least six months prior, and be able to stand and walk, even with help from devices or braces. They must also be able to understand and follow instructions in English. Participants will be asked to commit to 12 weeks of the program. It's important to note that individuals with certain medical conditions, such as severe heart problems or uncontrolled pain, won't be able to participate for safety reasons. Overall, this trial aims to find a fun and effective way to support recovery for those living with the effects of a stroke.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 45 to 90 years of age.
• • Able to follow instructions provided in English.
• • History of neurological impairment (Stroke) for at least 6 months prior to evaluation (self-report, confirmed by participant's physician).
• • Able to stand and walk with or without assistive device or braces as part of their activities of daily living (self-report).
• • Cognitive skills to actively participate (score of \< 26 on Montreal cognitive assessment indicates cognitive impairment).
• • Stroke - a) Upper extremity limb function (score of at least 25 on the Fugyl Myer Upper extremity test and Muscle performance grade on deltoid, pec major and and triceps of \> or = 2/5).
• Exclusion Criteria:
• • Cognitive or communicative impairment indicated by a score of \> 26 on Montreal cognitive assessment and a score of \<25 on Mini Mental State Exam Score;
• • aphasia \<71% on Mississippi Aphasia Screening Test
• • \>15 on Geriatric Depression Scale.
• • unhealed pressure sores,
• • active or untreated infection,
• • thromboembolic disease,
• • severe contractures,
• • active heterotrophic ossification in the lower extremities,
• • lower limb fractures,
• • known history of peripheral nerve injury in the lower legs,
• • history of cardiovascular or pulmonary complications, or with pacemakers and history of metabolic (endocrine, hepatic) or renal dysfunction, uncontrolled seizures (Self-report).
• • History of any acute and significant cardiopulmonary, musculoskeletal or systemic diagnosis in the past 6 months or history of a recent major surgery (\<6months) or hospitalization (\<3months) and on any sedative drugs.
• • Partcipants unavailable for 12 weeks of participation,
• • Current participation in other treatment (i.e.- Botox) or other research studies during the phase of the study.
• • Pregnancy.
• • Uncontrolled pain \>3/10 on VAS.
• • Complains of shortness of breath
• • Uncontrolled hypertension (systolic blood pressure (SBP) \> 165 mmHg and/or diastolic blood pressure (DBP) \> 110 mmHg during resting).
• • Resting hear rate (HR) \> 85% of age-predicted maximal heart rate (HRmax) (HRmax = 220 - age) \[3\].
• • Oxygen saturation (measured by pulse oximeter) during resting \< 95%.
• • Severe cardiac disease (New York Heart Association classification of IIIV) \[1\]. Exclusion Criteria for Laboratory Slip test.
• • T score of \< -2 on the Bone density, measured through via the heel ultrasound machine.